full record print

Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]

author
Kovacovicova, Kristina
Školnaja, Marianna
Heinmaa, Mihkel
Mistrik, Martin
Pata, Pille
Pata, Illar
statement of authorship
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
source
journal volume number month
vol. 8
year of publication
pages
art. 459, 7 p. : ill
url
ISSN
2234-943X
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
Reserch Group
Laboratory of biofunctional materials
Microfluidics group
Kovacovicova, K.; Školnaja, M.; Heinmaa, M.; Mistrik, M.; Pata, P.; Pata, I. et al. Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource] // Frontiers in oncology (2018) vol. 8, art. 459, 7 p. : ill. https://doi.org/10.3389/fonc.2018.00459